PapersPMID:31343402
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“Low-dose theophylline had no significant effects on lung function (i.e. FEV1), incidence of pneumonia, mortality, breathlessness or measures of quality of life or disease impact.”
- Study
- RCT
- Duration
- 12 months
- Dose studied
- 200 mg once or twice a day, determined by ideal body weight and smoking status
- Population
- Adults with COPD (FEV1/FVC < 0.7) at high risk of exacerbation, on a drug regimen including inhaled corticosteroids in both arms, with two or more treated exacerbations in the previous year
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- People with COPD currently on a drug regimen including inhaled corticosteroids with a history of two or more exacerbations treated with antibiotics and/or oral corticosteroids in the previous year
- Participants
- 1,578
- Comparator
- placebo
- Duration
- 365 days
- Endpoints measured
- 9